Comerica Bank Hutchmed (China) LTD Transaction History

Comerica Bank

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 22, 2021	SELL	$35.66 - $42.94 $336,452 - $405,138	-9,435 Closed	0 $0
Q2 2021 Aug 26, 2021	BUY	$23.7 - $39.27 $1,896 - $3,141	80 Added 0.86%	9,435 $370,000
Q1 2021 Apr 28, 2021	BUY	$27.01 - $36.8 $7,724 - $10,524	286 Added 3.15%	9,355 $264,000
Q4 2020 Jan 28, 2021	BUY	$27.51 - $34.36 $12,076 - $15,084	439 Added 5.09%	9,069 $290,000
Q3 2020 Oct 30, 2020	BUY	$25.8 - $34.61 $6,063 - $8,133	235 Added 2.8%	8,630 $278,000
Q2 2020 Jul 31, 2020	BUY	$17.65 - $28.05 $148,171 - $235,479	8,395 New	8,395 $231,000
Q2 2019 Aug 02, 2019	SELL	$22.0 - $31.78 $164,230 - $237,237	-7,465 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$21.27 - $30.58 $158,780 - $228,279	7,465 New	7,465 $0
Q4 2018 Feb 06, 2019	SELL	$23.09 - $37.69 $161,606 - $263,792	-6,999 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$26.55 - $34.38 $10,354 - $13,408	390 Added 5.9%	6,999 $209,000
Q2 2018 Aug 01, 2018	BUY	$27.79 - $34.49 $277 - $344	10 Added 0.15%	6,609 $210,000
Q1 2018 May 01, 2018	BUY	$28.87 - $41.13 $2,309 - $3,290	80 Added 1.23%	6,599 $222,000
Q3 2017 Nov 06, 2017	BUY	$22.15 - $27.5 $144,395 - $179,272	6,519	6,519 $203,000

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.57B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.